Co-Diagnostics, Inc. (CODX) Capital expenditures 2016–2025
Co-Diagnostics, Inc. (CODX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$700,047FY2025 · since FY2016: $12,241 → $700,047
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $700,047 | -6.5% |
| FY2024 | $748,352 | -45.2% |
| FY2023 | $1.4M | -4.4% |
| FY2022 | $1.4M | +113.2% |
| FY2021 | $669,463 | -13.6% |
| FY2020 | $774,397 | +583.8% |
| FY2019 | $113,246 | +174.0% |
| FY2018 | $41,336 | -68.0% |
| FY2017 | $129,306 | +956.3% |
| FY2016 | $12,241 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice